• 1
    Sipe, J. (1992) Amyloidosis. Annu. Rev. Biochem. 61, 947975.
  • 2
    Fraser, P.E., Nguyen, J.T., Chin, D.T. & Kirschner, D.A. (1992) Effects of sulfate ions on Alzheimer β/A4 peptide assemblies: implications for amyloid fibril–proteoglycan interactions. J. Neurochem. 59, 15311540.
  • 3
    Gupta-Bansal, R., Frederickson, R.C.A. & Brunden, K.R. (1995) Proteoglycan-mediated inhibition of A β proteolysis. A potential cause of senile plaque accumulation. J. Biol. Chem. 270, 1866618671.
  • 4
    Shaffer, L.M., Dority, M.D., Gupta-Bansal, R., Frederickson, R.C.A., Younkin, S.G. & Brunden, K.R. (1995) Amyloid β protein (A β) removal by neuroglial cells in culture. Neurobiol. Aging 16, 737745.
  • 5
    Castillo, G.M., Ngo, C., Cummings, J., Wight, T.N. & Snow, A.D. (1997) Perlecan binds to the β-amyloid proteins (A β) of Alzheimer’s disease, accelerates A β fibril formation, and maintains A β fibril stability. J. Neurochem. 69, 24522465.
  • 6
    Sunde, M., Serpell, L.C., Bartlam, M., Fraser, P.E., Pepys, M.B. & Blake, C.C.F. (1997) Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J. Mol. Biol. 273, 729793.
  • 7
    Snow, A.D. & Kisilevsky, R. (1985) Temporal relationship between glycosaminoglycan accumulation and amyloid deposition during experimental amyloidosis. A histochemical study. Lab. Invest. L53, 3744.
  • 8
    Snow, A.D., Mar, H., Nochlin, D., Kimata, K., Kato, M., Suzuki, S., Hassell, J. & Wight, T.N. (1988) The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer’s disease. Am. J. Pathol. 133, 456463.
  • 9
    Snow, A.D., Nochlin, D., Sekiguchi, R. & Carlson, S.S. (1996) Identification in immunolocalization of a new class of proteoglycan (keratan sulfate) to the neuritic plaques of Alzheimer’s disease. Exp. Neurol. 138, 305317.
  • 10
    Snow, A.D., Mar, H., Nochlin, D., Kresse, H. & Wight, T.N. (1992) Peripheral distribution of dermatan sulfate proteoglycans (decorin) in amyloid-containing plaques and their presence in neurofibrillary tangles of Alzheimer’s disease. J. Histochem. Cytochem. 40, 105113.
  • 11
    Dewitt, D.A., Silver, J., Canning, D.R. & Perry, G. (1993) Chondroitin sulfate proteoglycans are associated with the lesions of Alzheimer’s disease. Exp. Neurol. 121, 149152.
  • 12
    Perry, G., Siedlak, S.L., Richey, P., Kawai, M., Cras, P., Kalana, R.N., Galloway, P.G., Scardin, J.M., Cordell, B., Greenberg, B.D., Ledbetter, S.R. & Gambetti, P. (1991) Neurophil threads of Alzheimer’s disease show a marked alteration of the normal cytoskeleton. J. Neurosci. 11, 36793683.
  • 13
    Su, J.H., Cummings, B.J. & Cotman, W. (1992) Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer’s disease. Neuroscience 51, 801813.
  • 14
    Goedert, M., Jakes, R., Spillantini, M.G., Hasegawa, M., Smith, M.J. & Crowther, R.A. (1996) Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature 383, 550553.
  • 15
    Buée, L., Ding, W., Delacourte, A. & Fillit, H. (1993) Binding of vascular heparan sulfate proteoglycan to Alzheimer’s amyloid precursor protein is mediated in part by the N-terminal region of A4 peptide. Brain Res. 601, 154163.
  • 16
    Buée, L., Ding, W., Anderson, J.P., Narindrasorasak, S., Kisilevsky, R., Boyle, N.J., Robakis, N.K., Delacourte, A., Greenberg, B. & Fillit, H.M. (1993) Binding of secreted human neuroblastoma proteoglycans to the Alzheimer’s amyloid A4 peptide. Brain Res. 627, 199204.
  • 17
    Snow, A.D., Kinsella, M.G., Parks, E., Sekiguchi, R.T., Miller, J.D., Kimata, K. & Wight, T.N. (1995) Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the β-amyloid protein of Alzheimer’s disease. Arch. Biochem. Biophys. 320, 8495.
  • 18
    Brunden, K.R., Richter-Cook, N.J., Chaturvedi, N. & Fredrickson, R.C.A. (1993) pH-dependent binding of synthetic β-amyloid peptides to glycosaminoglycans. J. Neurochem. 61, 21472154.
  • 19
    Gupta-Bansal, R. & Brunden, K.R. (1998) Congo red inhibits proteoglycan and serum amyloid P binding to amyloid β fibrils. J. Neurochem. 70, 292298.
  • 20
    Jao, S., Ma, K., Talafous, J., Orlando, R. & Zagorski, M.G. (1997) Trifluoroacetic acid pretreatment reproducibly disaggregates the amyloid β-peptide. Amyloid: Int. J. Exp. Clin. Invest. 4, 240252.
  • 21
    Huang, T.H.J., Fraser, P.E. & Chakrabartty, A. (1997) Fibrillogenesis of Alzheimer Aß peptides studied by fluorescence energy transfer. J. Mol. Biol. 269, 214224.
  • 22
    McLaurin, J., Franklin, T., Chakrabartty, A. & Fraser, P.E. (1998) Phosphatidylinositol and inositol involvement in Alzheimer amyloid-β fibril growth and arrest. J. Mol. Biol. 278, 183194.
  • 23
    Kirschner, D.A., Abraham, C. & Selkoe, D.J. (1986) X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-β conformation. Proc. Natl Acad. Sci. USA 83, 503507.
  • 24
    Halverson, K., Fraser, P.E., Kirschner, D.A. & Lansbury, P.T. (1990) Molecular determinants of amyloid deposition in Alzheimer’s disease: conformational studies of synthetic β-protein fragments. Biochemistry 29, 26392644.
  • 25
    Hilbich, C., Kisters-Woike, B., Reed, J., Masters, C.L. & Beyreuther, K. (1991) Aggregation and secondary structure of synthetic amyloid β A4 peptides of Alzheimer’s disease. J. Mol. Biol. 218, 149163.
  • 26
    Lomakin, A., Chung, D.S., Benedek, G.B., Kirschner, D.A. & Teplow, D.B. (1996) On the nucleation and growth of amyloid β-protein fibrils: detection of nuclei and quantitation of rate constants. Proc. Natl Acad. Sci. USA 93, 11251129.
  • 27
    Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schlossmacher, M., Whaley, J., Swindlehurst, C., McCormack, R., Wolfert, R., Selkoe, D., Lieberburg, I. & Schenk, D. (1992) Isolation and quantification of soluble Alzheimer’s β-peptide from biological fluids. Nature 359, 325327.
  • 28
    Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F. & Cole, G. (1996) Memory deficits, A β elevation and amyloid plaques in transgenic mice. Science 274, 99102.
  • 29
    Barrow, C.J. & Zagorski, M.G. (1991) Solution structures of β peptide and its constituent fragments: relation to amyloid deposition. Science 253, 179182.
  • 30
    Sticht, H., Bayer, P., Willbold, D., Dames, S., Hilbich, C., Beyreuther, K., Frank, R.W. & Rosch, P. (1995) Structure of amyloid A4-(1–40)-peptide of Alzheimer’s disease. Eur. J. Biochem. 233, 293298.
  • 31
    Terzi, E., Holzemann, G. & Seelig, J. (1995) Self-association of β-amyloid peptide (1–40) in solution and binding to lipid membranes. J. Mol. Biol. 252, 633642.
  • 32
    McLaurin, J. & Chakrabartty, A. (1996) Membrane disruption by Alzheimer β-amyloid peptides mediated through specific binding to either phospholipids or gangliosides; implications for neurotoxicity. J. Biol. Chem. 271, 2648226489.
  • 33
    Fraser, P.E., Nguyen, J.T., McLachlan, D.R., Abraham, C.R. & Kirschner, D.A. (1993) α 1-antichymotrypsin binding to Alzheimer A β peptides is sequence specific and induces fibril disaggregation in vitro. J. Neurochem. 61, 298305.
  • 34
    Wisniewski, T., Castano, E.M., Golabek, A., Vogel, T. & Frangione, B. (1994) Acceleration of Alzheimer’s fibril formation by apolipoprotein E in vitro. Am. J. Pathol. 145, 10301034.
  • 35
    Evans, K.C., Berger, E.P., Cho, C.-G., Weisgraber, K.H. & Lansbury, P.T. Jr (1995). Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease. Proc. Natl Acad. Sci. USA 92, 763767.
  • 36
    Eriksson, S., Janciauskiene, S. & Lannfelt, L. (1995) α 1-antichymotrypsin regulates Alzheimer β-amyloid peptide fibril formation. Proc. Natl Acad. Sci. USA 92, 23132317.
  • 37
    McLaurin, J., Franklin, T., Fraser, P.E. & Chakrabartty, A. (1997) Structural transitions associated with the interaction of Alzheimer β-amyloid peptides with gangliosides. J. Biol. Chem. 273, 45064515.
  • 38
    Webster, S. & Rogers, J. (1996) Relative efficacies of amyloid β peptide (A β) binding proteins in A β aggregation. J. Neurosci. Res. 46, 5866.
  • 39
    Walsh, D.M., Lomakin, A., Benedek, G.B., Condron, M.M. & Teplow, D.B. (1997) Amyloid β-protein fibrillogenesis. Detection of a protofibrillar intermediate. J. Biol. Chem. 272, 2236422372.
  • 40
    Booth, D.R., Sunde, M., Bellotti, V., Robinson, C.V., Hutchinson, W.L., Fraser, P.E., Hawkins, P.N., Dobson, C.M., Radford, S.E., Blake, C.C.F. & Pepys, M.B. (1997) Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature 385, 787793.
  • 41
    Jarrett, J.T., Berger, E.P. & Lansbury, P.T. (1993) Seeding ‘one-dimensional crystallization’ of amyloid: a pathogenic mechanism in Alzheimer’s disease and scrapie? Biochemistry 32, 46934697.
  • 42
    Jarrett, J.T. & Lansbury, P.T. (1993) The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer’s disease. Cell 73, 10551058.
  • 43
    Cai, X.-D., Golde, T.E. & Younkin, G.S. (1993) Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 259, 514516.
  • 44
    Citron, M., Vigo-Pelfrey, C., Teplow, D.B., Miller, C., Schenk, D., Johnston, J., Winblad, B., Venizelos, N., Lannfelt, L. & Selkoe, D. (1994) Excessive production of amyloid β-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. Proc. Natl Acad. Sci. USA 91, 1199311997.
  • 45
    Suzuki, N., Cheung, T.T., Cai, X.D., Odaka, A., Otvos, L. Jr, Eckman, C., Golde, T.E. & Younkin, S.G. (1994) An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (beta APP717) mutants. Science 264, 13361340.
  • 46
    Stritmater, W.J. & Roses, A.D. (1995) Apolipoprotein E and Alzheimer disease. Proc. Natl Acad. Sci. USA 92, 47254727.
  • 47
    Narindrasorasak, S., Lowery, D., Gonzalez-DeWhitt, P., Poorman, R.A., Greenberg, B. & Kisilevsky, R. (1991) High affinity interactions between the Alzheimer’s β-amyloid precursor proteins and the basement membrane form of heparan sulfate proteoglycan. J. Biol. Chem. 266, 1287812883.
  • 48
    Small, D.H., Nurcombe, V., Reed, G., Clarris, H., Moir, R., Beyreuther, K. & Masters, C.L. (1994) A heparin-binding domain in the amyloid protein precursor of Alzheimer’s disease is involved in the regulation of neurite outgrowth. J. Neurosci. 12, 41434150.
  • 49
    Arrasate, M., Perez, M., Valpuesta, J.M. & Avila, J. (1997) Role of glycosaminoglycans in determining the helicity of paired helical filaments. Am. J. Pathol. 151, 11151122.
  • 50
    Castillo, G.M., Lukito, W., Wight, T.N. & Snow, A.D. (1999) The sulfate moieties of glycosaminoglycans are critical for the enhancement of β-amyloid protein fibril formation. J. Neurochem. 72, 16811687.
  • 51
    Jiang, X., Myatt, E., Lykos, P. & Stevens, F.J. (1997) Interaction between glycosaminoglycans and immunoglobulin light chains. Biochemistry 36, 1318713194.
  • 52
    McCubbin, W.D., Kay, C.M., Narindrasorasak, S. & Kisilevsky, R. (1988) Circular-dichroism studies on two murine serum amyloid A proteins. Biochem. J. 256, 775783.
  • 53
    Fraser, P.E., McLachlan, D.R., Surewicz, W.K., Mizzen, C.A., Snow, A.D., Nguyen, J.T. & Kirschner, D.A. (1994) Conformation and fibrillogenesis of Alzheimer A β peptides with selected substitution of charged residues. J. Mol. Biol. 244, 6473.
  • 54
    Levengle, B., Scanameo, A., Ding, W. & Fillit, H. (1994) Binding of heparan sulfate glycosaminoglycan to β-amyloid peptide: inhibition by potentially therapeutic polysulfated compounds. Neuroreport 5, 13891392.
  • 55
    Kisilevsky, R., Lemieux, L.J., Fraser, P.E., Kong, X., Hultin, P.G. & Szarek, W. (1995) Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates implications for Alzheimer’s disease. Nature Med. 1, 143148.